Literature DB >> 9971792

The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo.

M P Weekes1, M R Wills, K Mynard, A J Carmichael, J G Sissons.   

Abstract

Human cytomegalovirus (HCMV)-specific CD8(+) cytotoxic T lymphocytes (CTL) appear to play an important role in the control of virus replication and in protection against HCMV-related disease. We have previously reported high frequencies of memory CTL precursors (CTLp) specific to the HCMV tegument protein pp65 in the peripheral blood of healthy virus carriers. In some individuals, the CTL response to this protein is focused on only a single epitope, whereas in other virus carriers CTL recognized multiple epitopes which we identified by using synthetic peptides. We have analyzed the clonal composition of the memory CTL response to four of these pp65 epitopes by sequencing the T-cell receptors (TCR) of multiple independently derived epitope-specific CTL clones, which were derived by formal single-cell cloning or from clonal CTL microcultures. In all cases, we have observed a high degree of clonal focusing: the majority of CTL clones specific to a defined pp65 peptide from any one virus carrier use only one or two different TCRs at the level of the nucleotide sequence. Among virus carriers who have the same major histocompatibility complex (MHC) class I allele, we observed that CTL from different donors that recognize the same peptide-MHC complex often used the same Vbeta segment, although other TCR gene segments and CDR3 length were not in general conserved. We have also examined the clonal composition of CTL specific to pp65 peptides in asymptomatic human immunodeficiency virus-infected individuals. We have observed a similarly focused peptide-specific CTL response. Thus, the large population of circulating HCMV peptide-specific memory CTLp in virus carriers in fact contains individual CTL clones that have undergone extensive clonal expansion in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971792      PMCID: PMC104454          DOI: 10.1128/JVI.73.3.2099-2108.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A persistent T cell expansion in the peripheral blood of a normal adult male: a new clinical entity?

Authors:  J Grunewald; M Jeddi-Tehrani; H Dersimonian; R Andersson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction.

Authors:  W M Rosenberg; P A Moss; J I Bell
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

3.  Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.

Authors:  E A Kabat; T T Wu
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics.

Authors:  J L Jorgensen; U Esser; B Fazekas de St Groth; P A Reay; M M Davis
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

5.  Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.

Authors:  B S Peters; E J Beck; S Anderson; D Coleman; R Coker; J Main; C Migdal; J R Harris; A J Pinching
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

6.  Organization of the T-cell receptor alpha-chain gene and rearrangement in human T-cell leukaemias.

Authors:  R Baer; M P Lefranc; J Minowada; A Forster; M A Stinson; T H Rabbitts
Journal:  Mol Biol Med       Date:  1986-06

7.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

Authors:  S R Riddell; K S Watanabe; J M Goodrich; C R Li; M E Agha; P D Greenberg
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

8.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

Authors:  P Reusser; S R Riddell; J D Meyers; P D Greenberg
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

9.  Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity.

Authors:  L K Borysiewicz; S Graham; J K Hickling; P D Mason; J G Sissons
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

10.  The genetic contribution to human T-cell receptor repertoire.

Authors:  J A Loveridge; W M Rosenberg; T B Kirkwood; J I Bell
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

View more
  58 in total

1.  CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes.

Authors:  M C Cheeran; G Gekker; S Hu; S L Yager; P K Peterson; J R Lokensgard
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  Ex vivo analysis of phenotype and TCR usage in relation to CD45 isoform expression on cytomegalovirus-specific CD8+ T lymphocytes.

Authors:  A L Vargas; F Lechner; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.

Authors:  Rafaela Holtappels; Doris Thomas; Jürgen Podlech; Matthias J Reddehase
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.

Authors:  Michael P Weekes; Mark R Wills; J G Patrick Sissons; Andrew J Carmichael
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

6.  Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old.

Authors:  Qin Ouyang; Wolfgang M Wagner; Anders Wikby; Steffen Walter; Geraldine Aubert; Anthony I Dodi; Paul Travers; Graham Pawelec
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

7.  Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.

Authors:  Nina Babel; Gordon Brestrich; Lukasz P Gondek; Arne Sattler; Marcin W Wlodarski; Nina Poliak; Nicole Bethke; Andreas Thiel; Markus H Hammer; Petra Reinke; Jaroslaw P Maciejewski
Journal:  J Am Soc Nephrol       Date:  2008-09-17       Impact factor: 10.121

8.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

9.  Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Authors:  Eli M Eisenstein; Dana G Wolf
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-20       Impact factor: 3.054

10.  Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.

Authors:  Elena Sandalova; Diletta Laccabue; Carolina Boni; Anthony T Tan; Katja Fink; Eng Eong Ooi; Robert Chua; Bahar Shafaeddin Schreve; Carlo Ferrari; Antonio Bertoletti
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.